August 15, 2026 · Phase 2 readout
BIVI Phase 2 readout: a negative outcome, -33.8%
-33.8%BIOVIE INC. (BIVI) →
On August 15, 2026, NE3107 — BIOVIE INC. (Parkinsons Disease (PD)) reached its Phase 2 readout. The result was a negative outcome, and the stock moved -33.8% in the window around the event. It had already run -25.0% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.
The move
$2.04
1d before
$1.35
Event day
$1.00
1d after
$1.27
5d after
Our prediction vs. the result
CatalystAlert called this one neutral (+0.6% expected); the stock actually moved -33.8%. Model confidence at the time: 40%.
See the full scored track recordPre-catalyst setup
-25.0%
30-day run-up
16214%
30-day volatility
1.2×
volume spike